0000000000165090

AUTHOR

D. Angulo-gonzalez

showing 2 related works from this author

Posaconazole vs Standard Azole (FLU/ITRA) Therapy for Prophylaxis of Invasive Fungal Infections (IFIs) among High-Risk Neutropenic Patients: Results …

2005

Abstract Background: Patients with severe and prolonged neutropenia are at high-risk of developing life-threatening IFIs. Despite current treatment option, IFIs are difficult to treat and frequently associated with high mortality rates. Antifungal prophylaxis has shown benefits in high-risk populations and is a standard practice in many institutions. We compared Posaconazole (POS), a new broad-spectrum triazole, vs Standard Azoles for the prevention of IFIs in patients with a new diagnosis or first relapse of acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) being treated with intensive chemotherapy. Methods: Patients in this randomized, evaluator-blinded, active controlled…

medicine.medical_specialtyPosaconazoleItraconazolebusiness.industryImmunologyCell BiologyHematologyNeutropeniamedicine.diseaseBiochemistrySurgeryDiscontinuationTolerabilityInternal medicineMulticenter trialmedicineAdverse effectbusinessFluconazolemedicine.drugBlood
researchProduct

A multicenter, randomized trial of posaconazole (POS) vs fluconazole (FLU) or itraconazole (ITZ) for prophylaxis of invasive fungal infections (IFIs)…

2006

Posaconazolemedicine.medical_specialtyTransplantationAcute myelogenous leukemia (AML)Itraconazolebusiness.industryvirusesvirus diseasesIntensive chemotherapyHematologymedicine.diseaselaw.inventionRandomized controlled triallawInternal medicineImmunologymedicinebusinessFluconazolemedicine.drugBiology of Blood and Marrow Transplantation
researchProduct